Publications
266
Citations
25,154
Est. group size
~11
Recurring co-author estimate
Active years
40
Publishing since 1987
Ray E. Hershberger studies the genetic causes of heart muscle diseases, particularly dilated cardiomyopathy (a condition where the heart muscle weakens and enlarges, reducing its pumping ability) and related inherited cardiac conditions. His work spans clinical genetic testing standards, family-based genetic studies, and clinical trials testing new drug treatments for these heart conditions. Prospective students would likely engage with a mix of clinical genetics research, large multi-site studies, and translational cardiology.
Publication output has remained fairly steady over the past decade, averaging about 10 papers per year, with some year-to-year fluctuation and a notable peak in 2023.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 26-A-11295-ACC DANICAMTIV TREATMENT FOR PATIENTS WITH DILATED CARDIOMYOPATHY: FINDINGS FROM A PHASE 2 OPEN-LABEL EXTENSION
Journal of the American College of Cardiology · 2026
- ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine · 2025
- Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy
Journal of the American College of Cardiology · 2025
- Systemic Immune-Mediated Diseases and Dilated Cardiomyopathy
JACC Heart Failure · 2025
- Clinical Validity of Autosomal Dominant <i>ALPK3</i> Loss-of-Function Variants as a Cause of Hypertrophic Cardiomyopathy
Circulation Genomic and Precision Medicine · 2025
- CMR identifies early dilated cardiomyopathy in genetically at-risk individuals: preliminary results from the DCM precision medicine CMR study.
Journal of Cardiovascular Magnetic Resonance · 2025
- Early Phenotype Identification
JACC. Cardiovascular imaging · 2025
- ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
UNC Libraries · 2025
- Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
UNC Libraries · 2025
- Systemic barriers and opportunities for equity in early implementation of genetic testing and counseling for cardiomyopathies in Tanzania
Communications Medicine · 2025
- REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic <i>LMNA</i> -Related Dilated Cardiomyopathy
Circulation Heart Failure · 2024
- Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in <i>BAG3</i>
JAMA Cardiology · 2024
- The GENESIS database and tools: A decade of discovery in Mendelian genomics
Experimental Neurology · 2024
- Monoallelic TTN Truncation Variants Identified in Individuals With DCM May Cause a Mild Skeletal Myopathy
JACC Heart Failure · 2024
- Abstract 4145070: Genetic and Family Analysis of Probands with Peripartum Cardiomyopathy and Dilated Cardiomyopathy and Their First-Degree Relatives
Circulation · 2024
- Circulation×14
- Circulation Genomic and Precision Medicine×13
- Genetics in Medicine×12
- Journal of the American College of Cardiology×8
- medRxiv×8
- Brandon J. Biesiadecki
Medicine · The Ohio State University
- Heather R. Manring
Medicine · The Ohio State University
- Shane D. Walton
Medicine · The Ohio State University
- Lorien Salyer
Medicine · The Ohio State University
- Sarah L. Sturgill
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile